2019
DOI: 10.1097/aco.0000000000000724
|View full text |Cite
|
Sign up to set email alerts
|

Clonidine in pediatric anesthesia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
6
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
4
3

Relationship

1
6

Authors

Journals

citations
Cited by 13 publications
(6 citation statements)
references
References 62 publications
0
6
0
Order By: Relevance
“…In addition to analgesia, clonidine reduces nausea, anesthesia requirements, and emergence delirium. Clonidine also reduces anesthesia induction time, oxygen consumption, and has myocardial protective qualities [ 3 , 4 ]. Recently, it has been shown to be similarly effective to midazolam in reducing postoperative negative behavioral changes [ 3 ].…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…In addition to analgesia, clonidine reduces nausea, anesthesia requirements, and emergence delirium. Clonidine also reduces anesthesia induction time, oxygen consumption, and has myocardial protective qualities [ 3 , 4 ]. Recently, it has been shown to be similarly effective to midazolam in reducing postoperative negative behavioral changes [ 3 ].…”
Section: Introductionmentioning
confidence: 99%
“…Recently, it has been shown to be similarly effective to midazolam in reducing postoperative negative behavioral changes [ 3 ]. The onset time for oral clonidine is 30–60 min, and the half life is around 12 h. The peak effects are within 60–90 min [ 4 ]. It also has an excellent safety profile with a very low incidence of bradycardia when dosed appropriately (less than 1%) [ 5 ].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Clonidine is often used off‐label for different indications, including sedation, pain, and prevention of emergence agitation 8–11 . Several clinical trials have previously found beneficial effects of clonidine as an adjunctive agent for the prevention of emergence agitation in children over 1 year 3,12 . The PREVENT AGITATION trial in children 1–5 years of age found a decrease in episodes of emergence agitation in the clonidine (3 μg/kg) group compared with the placebo group (RR 0.56, 95% CI: 0.43–0.73) 13 .…”
Section: Introductionmentioning
confidence: 99%
“…[8][9][10][11] Several clinical trials have previously found beneficial effects of clonidine as an adjunctive agent for the prevention of emergence agitation in children over 1 year. 3,12 The PREVENT AGITATION trial in children 1-5 years of age found a decrease in episodes of emergence agitation in the clonidine (3 μg/kg) group compared with the placebo group (RR 0.56, 95% CI: 0.43-0.73). 13 However, there is little published evidence on emergence agitation in children under 1 year, 14 and it is difficult to extrapolate dose recommendations from older age groups due to developmental considerations.…”
mentioning
confidence: 99%